Exabis Library
Welcome to the e-CCO Library!
P211: Anti-tumour necrosis factor drugs levels and correlation with short-term clinical remission in Crohn’s disease patients: results from the Predicrohn Study
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P211: Association of disease activity and quality of life with dietary habits in patients with inflammatory bowel disease
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P211: Differences in therapeutic approaches and outcomes in paediatric and adult onset Crohn's disease with perianal fistula: comparison of 2 multicentre fistula cohorts
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P211: Factors associated with estimated cardiorespiratory fitness in patients with Inflammatory Bowel Disease: an exploratory analysis of real-world data
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:48 AM
P211: Pseudopolyps are associated with increased fecal calprotectin levels in patients with Inflammatory Bowel Disease in clinical and endoscopic remission.
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P211: Relationship between the concentrations of free sulphates and 5-hydroxyindoleacetic acid (5-HIAA) in urine for IBD patients
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P211: Vaccination against Sars-Cov-2 in IBD patients: experience from a single tertiary referral centre
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P212 Deep learning video analysis for a fully automated per-frame grading of ulcerative colitis
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P212: Assessment of Crohn's disease activity using global MaRIA score in patients with ileal and ileocolonic disease
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P212: Diagnostic approach to monogenic inflammatory bowel disease in clinical practice: a 10-year multi-centric experience
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P212: Inflammatory bowel disease patients seem to develop non-alcoholic steatohepatitis (NASH) independently from an altered metabolic profile or active bowel disease
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P212: Location and Kudo pit pattern reflect neoplastic histology of lesions detected at surveillance colonoscopy in inflammatory bowel disease
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P212: Serum and tissue levels of malondialdehyde, total antioxidant system, toll-like Receptor 4 in inflammatory bowel disease: A correlation analysis of these markers with faecal calprotectin, C-reactive protein and erythrocyte sedimentation rate
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P212: The DUBLIN Score is a Useful Tool for Predicting Disease Course in Patients with Ulcerative Colitis
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P212: The Impact of Crohn's Disease in Patients with Colorectal Cancer: A Danish Nationwide Cohort Study, 2009-2019
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:48 AM
P213 Can artificial intelligence help differentiate inflammatory intestinal diseases in China? Models applying random forest and convolutional neuron network
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P213: Agreement between Crohn's disease endoscopy severity scores derived from live local, delayed local video-recorded and central readings
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P213: Having Inflammatory Bowel Disease Negatively Impacts Household and Family Life
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P213: High prevalence and risk factors for nonalcoholic fatty liver disease in patients with Crohn's disease
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:48 AM
P213: Predicting outcome of paediatric Crohn’s disease: role of clinical, endoscopic, and imaging findings at the diagnosis
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM